 Eledon Pharmaceuticals, Inc. NASDAQ:ELDN Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Paul Little Chief Financial Officer David-Alexandre Gros Chief Executive Officer Steve Perrin President and Chief Scientific Officer Jeff Bornstein Chief Medical Officer Conference Call Participants Pete Stavropoulos Cantor Fitzgerald Matt Kaplan Ladenburg Thalmann Thomas Smith SVB Securities Rami Katkhuda LifeSci Capital Operator Good day and welcome to the Eledon Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode. 